Discussion of Pharmaceutical Reimbursement Policies Under Global Budget System in Taiwan’s National Health Insurance
The national health insurance with universal coverage in Taiwan has been implemented for more than twenty years. Although the national health insurance wins a lot of applause from the world, it needs to overcome many difficulties posed by an aging population, technological innovation in medicine, and global budget restriction. Because the global budget system in the health insurance determines the drug dispensing and fee schedule, the Bureau of National Health Insurance is forced to use the results of the drug price survey to reduce the fee schedule every year. This price reduction results make global pharmaceutical companies withdrawing their products from Taiwan and local pharmaceutical companies struggling in the market. This article focuses on the laws and policies for drug payment under the global budget system, and gives recommendations for improvement.